Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus

B Raman, DA Bluemke, TF Lüscher… - European heart …, 2022 - academic.oup.com
Emerging as a new epidemic, long COVID or post-acute sequelae of coronavirus disease
2019 (COVID-19), a condition characterized by the persistence of COVID-19 symptoms …

COVID-19 and cardiovascular disease: from bench to bedside

MK Chung, DA Zidar, MR Bristow, SJ Cameron… - Circulation …, 2021 - ahajournals.org
A pandemic of historic impact, coronavirus disease 2019 (COVID-19) has potential
consequences on the cardiovascular health of millions of people who survive infection …

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection

M Patone, XW Mei, L Handunnetthi, S Dixon… - Nature medicine, 2022 - nature.com
Although myocarditis and pericarditis were not observed as adverse events in coronavirus
disease 2019 (COVID-19) vaccine trials, there have been numerous reports of suspected …

2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute …

Writing Committee, TJ Gluckman, NM Bhave… - Journal of the American …, 2022 - jacc.org
The American College of Cardiology (ACC) has a long history of develo** documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …

Cardiovascular disease and COVID-19: a consensus paper from the ESC working group on coronary pathophysiology & microcirculation, ESC working group on …

E Cenko, L Badimon, R Bugiardini… - Cardiovascular …, 2021 - academic.oup.com
The cardiovascular system is significantly affected in coronavirus disease-19 (COVID-19).
Microvascular injury, endothelial dysfunction, and thrombosis resulting from viral infection or …

Stroke–heart syndrome: recent advances and challenges

JF Scheitz, LA Sposato, J Schulz‐Menger… - Journal of the …, 2022 - ahajournals.org
After ischemic stroke, there is a significant burden of cardiovascular complications, both in
the acute and chronic phase. Severe adverse cardiac events occur in 10% to 20% of …

Myocardial involvement after hospitalization for COVID-19 complicated by troponin elevation: a prospective, multicenter, observational study

J Artico, H Shiwani, JC Moon, M Gorecka, GP McCann… - Circulation, 2023 - ahajournals.org
Background: Acute myocardial injury in hospitalized patients with coronavirus disease 2019
(COVID-19) has a poor prognosis. Its associations and pathogenesis are unclear. Our aim …

Coronavirus disease 2019 and the athletic heart: emerging perspectives on pathology, risks, and return to play

JH Kim, BD Levine, D Phelan, MS Emery… - JAMA …, 2021 - jamanetwork.com
Importance Cardiac injury with attendant negative prognostic implications is common among
patients hospitalized with coronavirus disease 2019 (COVID-19) infection. Whether cardiac …

COVID and cardiovascular disease: what we know in 2021

M Chilazi, EY Duffy, A Thakkar, ED Michos - Current atherosclerosis …, 2021 - Springer
Abstract Purpose of Review Coronavirus disease 2019 (COVID-19) has been the cause of
significant global morbidity and mortality. Here, we review the literature to date of the short …

Coronavirus disease 2019–associated thrombosis and coagulopathy: review of the pathophysiological characteristics and implications for antithrombotic management

L Ortega‐Paz, D Capodanno… - Journal of the …, 2021 - ahajournals.org
Abstract Coronavirus disease 2019 (COVID‐19) is an infectious disease caused by severe
acute respiratory syndrome coronavirus‐2, which has posed a significant threat to global …